Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Life360 Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Life360 Inc. May 29, 202489.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 10, 2026 | Life360 Inc. | Option exercise | +8,021 | $2.15 | $17,245 |
| Aug 10, 2026 | Life360 Inc. | Option exercise | +1,744 | $8.19 | $14,283 |
| Aug 10, 2026 | Life360 Inc. | Open-market sale | −15,582 | $65.00 | $1,012,830 |
| Aug 4, 2026 | Life360 Inc. | Option exercise | +4,011 | $2.15 | $8,624 |
| Aug 4, 2026 | Life360 Inc. | Option exercise | +872 | $8.19 | $7,142 |
| Aug 4, 2026 | Life360 Inc. | Open-market sale | −10,701 | $60.00 | $642,060 |
| Jun 29, 2026 | Life360 Inc. | Open-market sale | −4,655 | $55.00 | $256,025 |
| May 29, 2026 | Life360 Inc. | Grant or award | +4,636 | — | — |
| Jun 30, 2025 | Life360 Inc. | Open-market sale | −448 | $63.23 | $28,327 |
| Jun 13, 2025 | Life360 Inc. | Option exercise | +13,742 | $2.15 | $29,545 |
| Jun 13, 2025 | Life360 Inc. | Option exercise | +11,663 | $13.35 | $155,701 |
| Jun 13, 2025 | Life360 Inc. | Option exercise | +12,702 | $8.19 | $104,029 |
| Jun 13, 2025 | Life360 Inc. | Open-market sale | −47,584 | $61.14 | $2,909,286 |
| May 29, 2025 | Life360 Inc. | Grant or award | +2,834 | — | — |
| May 29, 2024 | Life360 Inc. | Grant or award | +5,979 | — | — |
Questions about Brit Morin
What boards is Brit Morin on?
Brit Morin sits on the board of Life360 Inc.
How long has Brit Morin served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.